Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer
Clinical trial NCT03088930 · COMPLETED
Trial details
- NCT number
- NCT03088930
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-13
- Primary completion
- 2021-01-13
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.